A review article titled, ‘Prefibrotic myelofibrosis: recent updates in diagnosis, prognostication, and management 2026’ has just been published in Therapeutic Advances in Haematology.
The journal’s plain language summary explains:
‘Prefibrotic primary myelofibrosis (pre-PMF) is a subtype of myelofibrosis which has only recently been defined as a distinct condition in recent years. However, despite advances in diagnostic techniques and development of new genetic screening tests, the overall identification and management of this condition remain challenging. In this review article, we aim to give an overview on all the recent developments in the diagnosis, prognosis and also potential treatment pathway for patients diagnosed with pre-PMF. Finally, we discuss future trials and areas of research that could improve care for patients with this condition.’
With thanks to Therapeutic Advances in Hematology for enabling the full article to be free access:
